Vancouver, Canada

Michael Mezei

This inventor holds 1 USPTO granted patent. Top assignee: Chinoin, Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Mezei. Retrieved from https://idiyas.com/inventor/michael-mezei-y0hjfox6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovator Behind Liposome Composition: Michael Mezei

Introduction

Michael Mezei, an inventive mind based in Vancouver, Canada, has made significant contributions to the field of pharmaceuticals. With 1 patent to his name, he showcases a commitment to advancing medical science and improving health outcomes through innovative solutions.

Latest Patents

Mezei's notable patent involves a liposome composition containing selegiline, a breakthrough in drug formulation designed to enhance the delivery and efficacy of treatment options for various health conditions. This innovative composition represents a step forward in the field of targeted therapies.

Career Highlights

Michael Mezei’s career includes notable tenure at Chinoin, Ltd., a company recognized for its dedication to pharmaceutical advancements. His work entails not only inventing but also collaborating closely with other experts in the field to expand the horizons of pharmaceutical science.

Collaborations

Throughout his career, Mezei has collaborated with esteemed colleagues such as Jozsef Gaal and Gabor Szekacs. These partnerships reflect a shared vision among innovative minds to create influential advancements in the pharmaceutical sector.

Conclusion

In conclusion, Michael Mezei stands as a testament to the power of innovation in health care. With his work on liposome compositions and fruitful collaborations, he continues to contribute to the pharmaceutical industry, marking him as an inventor to watch in the years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…